Danish drugmaker Genmab and its U.S. partner AbbVie said on Friday that their drug for a type of blood cancer failed to ...

TRENTON, N.J. (AP) -- A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the ...

VLADIMIR Putin’s bid to launch Russia’s own version of Viagra has flopped, despite a £10 million state-funded research ...

(Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its ...

Medicine company Novartis (NVS) said on Thursday that a late-stage trial evaluating its drug Cosentyx in adults with newly diagnosed or relapsing giant cell arteritis failed to meet its primary goal ...

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients – and found a potential way to overcome that resistance. Team ...

July 18 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Friday its blockbuster drug Reblozyl in combination with another therapy failed to meet the main goal of a late-stage trial to ...

Pharma and biotech companies strive to develop therapeutics that move through preclinical and clinical trials quickly and efficiently, are safe and effective, and reach the market where they change ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Harmony Biosciences faces a ...

June 16 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the overall survival of patients in ...

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...